Author Archives: Warren Woessner

Biogen v. Serano – When is a Recombinant Polypeptide Novel?

Posted on May 27, 2021 by Warren Woessner

When I posted about this Fed. Cir. decision (Biogen MA v. EMD Serano, Appeal no. 2019-1133 (Fed. Cir., Sept. 28, 2020) on October 12, 2020, I viewed it as a straightforward application of the maxim that an otherwise non-novel product … Continue reading →

Posted in Anticipation | Tagged , , , | Leave a comment

Want an Expedited Decision on your Appeal? Use the USPTO’s Fast Track Appeals Pilot Program

Posted on May 5, 2021 by Warren Woessner

Guest post from the USPTO: What is the Fast-Track Appeals Pilot Program? Under the Fast-Track Appeals Pilot Program, appellants can have their ex parte appeals advanced out of turn. Appellants simply file a petition to request fast-track review of their … Continue reading →

Posted in PTAB, USPTO Practice and Policy | Tagged , , | Leave a comment

Listen to “A Conversation with Janice Mueller, Author of Mueller on Patent Law”

Posted on April 21, 2021 by Warren Woessner

Guest post from Chisum Patent Academy: The Chisum Patent Academy is pleased to share with you a recording of the recent webinar from Fastcase, Inc.: “A Conversation with Janice Mueller, Author of Mueller on Patent Law.” In the one-hour webinar, Janice answers questions about: … Continue reading →

Posted in Webinar | Tagged , | Leave a comment

Neapco’s Brief in Opposition to AA’s Petition for Cert.

Posted on April 9, 2021 by Warren Woessner

On March 31, 2021, Neapco Holdings LLC filed its Brief in Opposition to American Axle’s Petition for Cert. If you need a refresher on the proceedings to date, please read (or re-read) the analyses I posted on Jan. 11, 2021 … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment